These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 36232528)
1. Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury. Lee D; Tomita Y; Miwa Y; Shinojima A; Ban N; Yamaguchi S; Nishioka K; Negishi K; Yoshino J; Kurihara T Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232528 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide Mononucleotide Protects against Retinal Dysfunction in a Murine Model of Carotid Artery Occlusion. Lee D; Tomita Y; Miwa Y; Jeong H; Shinojima A; Ban N; Yamaguchi S; Nishioka K; Negishi K; Yoshino J; Kurihara T Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499037 [TBL] [Abstract][Full Text] [Related]
3. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway. Wei CC; Kong YY; Li GQ; Guan YF; Wang P; Miao CY Sci Rep; 2017 Apr; 7(1):717. PubMed ID: 28386082 [TBL] [Abstract][Full Text] [Related]
5. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia. Park JH; Long A; Owens K; Kristian T Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment. Chen X; Amorim JA; Moustafa GA; Lee JJ; Yu Z; Ishihara K; Iesato Y; Barbisan P; Ueta T; Togka KA; Lu L; Sinclair DA; Vavvas DG Aging (Albany NY); 2020 Dec; 12(24):24504-24521. PubMed ID: 33373320 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of nicotinamide mononucleotide on Alzheimer's disease through activating autophagy and anti-oxidative stress. Ma RY; Li L; Yang H; Zou B; Ma RX; Zhang Y; Wu MM; Chen P; Yao Y; Li J Biomed Pharmacother; 2024 Sep; 178():117199. PubMed ID: 39053426 [TBL] [Abstract][Full Text] [Related]
8. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice. Li HR; Liu Q; Zhu CL; Sun XY; Sun CY; Yu CM; Li P; Deng XM; Wang JF Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Wang X; Hu X; Yang Y; Takata T; Sakurai T Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898 [TBL] [Abstract][Full Text] [Related]
10. Melatonin and Nicotinamide Mononucleotide Attenuate Myocardial Ischemia/Reperfusion Injury via Modulation of Mitochondrial Function and Hemodynamic Parameters in Aged Rats. Hosseini L; Vafaee MS; Badalzadeh R J Cardiovasc Pharmacol Ther; 2020 May; 25(3):240-250. PubMed ID: 31645107 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion. Xu Z; Cho H; Hartsock MJ; Mitchell KL; Gong J; Wu L; Wei Y; Wang S; Thimmulappa RK; Sporn MB; Biswal S; Welsbie DS; Duh EJ J Neurochem; 2015 Apr; 133(2):233-41. PubMed ID: 25683606 [TBL] [Abstract][Full Text] [Related]
12. Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH. Nadtochiy SM; Wang YT; Nehrke K; Munger J; Brookes PS J Mol Cell Cardiol; 2018 Aug; 121():155-162. PubMed ID: 29958828 [TBL] [Abstract][Full Text] [Related]
13. Nicotinamide Mononucleotide: Research Process in Cardiovascular Diseases. Deng H; Ding D; Ma Y; Zhang H; Wang N; Zhang C; Yang G Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273473 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons. Chandrasekaran K; Choi J; Arvas MI; Salimian M; Singh S; Xu S; Gullapalli RP; Kristian T; Russell JW Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466541 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells. Ru M; Wang W; Zhai Z; Wang R; Li Y; Liang J; Kothari D; Niu K; Wu X Food Funct; 2022 Jul; 13(14):7507-7519. PubMed ID: 35678708 [TBL] [Abstract][Full Text] [Related]
16. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms. Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751 [TBL] [Abstract][Full Text] [Related]
17. Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice. Xu J; Chen X; Liu S; Wei Z; Xu M; Jiang L; Han X; Peng L; Gu X; Xia T Behav Brain Res; 2024 Feb; 458():114738. PubMed ID: 37931707 [TBL] [Abstract][Full Text] [Related]
18. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638 [TBL] [Abstract][Full Text] [Related]
19. Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis. Cao T; Ni R; Ding W; Ji X; Fan GC; Zhang Z; Peng T J Transl Med; 2023 Dec; 21(1):883. PubMed ID: 38057866 [TBL] [Abstract][Full Text] [Related]
20. Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation. Wu K; Li B; Lin Q; Xu W; Zuo W; Li J; Liu N; Tu T; Zhang B; Xiao Y; Liu Q Life Sci; 2021 Jun; 274():119299. PubMed ID: 33675899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]